The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
Open accessAbstract
Regulation of transcription factor Nrf2 (NF-E2-related factor 2) involves redox-sensitive proteasomal degradation via the E3 ubiquitin ligase Keap1/Cul3. However, Nrf2 is controlled by other mechanisms that have not yet been elucidated. We now show that glycogen synthase kinase 3 (GSK-3) phosphorylates a group of Ser residues in the Neh6 domain of mouse Nrf2 that overlap with an SCF/β-TrCP destruction motif (DSGIS, residues 334 to 338) and promotes its degradation in a Keap1-independent manner. Nrf2 was stabilized by GSK-3 inhibitors in Keap1-null mouse embryo fibroblasts. Similarly, an Nrf2(ΔETGE) mutant, which cannot be degraded via Keap1, accumulated when GSK-3 activity was blocked. Phosphorylation of a Ser cluster in the Neh6 domain of Nrf2 stimulated its degradation because a mutant Nrf2(ΔETGE 6S/6A) protein, lacking these Ser residues, exhibited a longer half-life than Nrf2(ΔETGE). Moreover, Nrf2(ΔETGE 6S/6A) was insensitive to β-TrCP regulation and exhibited lower levels of ubiquitination than Nrf2(ΔETGE). GSK-3β enhanced ubiquitination of Nrf2(ΔETGE) but not that of Nrf2(ΔETGE 6S/6A). The Nrf2(ΔETGE) protein but not Nrf2(ΔETGE 6S/6A) coimmunoprecipitated with β-TrCP, and this association was enhanced by GSK-3β. Our results show for the first time that Nrf2 is targeted by GSK-3 for SCF/β-TrCP-dependent degradation. We propose a "dual degradation" model to describe the regulation of Nrf2 under different pathophysiological conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Neh6 domain is a redox-insensitive degron that provides Keap1-independent negative Nrf2 regulation. Similar to Neh2, Neh6 contains two highly conserved 334DSGIS338 and 373DSAPGS378 motifs to which the β-transducin repeat-containing protein (βTrCP) binds, and within the DSGIS motif, a phosphorylation site for glycogen synthase kinase-3 (GSK3) that enhances βTrCP activity upon GSK3-mediated ph”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [62]
Citations
Cites
1 retracted
Phosphorylation of Tyrosine 568 Controls Nuclear Export of Nrf2
Jain, A. K., & Jaiswal, A. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511198200 · Cited by 171
Retractedβ‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,284
Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., & Harper, J. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80403-1 · Cited by 1,233
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D. D., Hannink, M., Arvisais, E. W., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,233
Cited by
Sorted by citations
Items 601–700 of 768
Tarot, P., Lasbleiz, C., & Liévens, J.-C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385283 · Cited by 9
Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment
Ngo, H. K. C., Le, H., & Surh, Y. (2023) · Journal of Cancer Prevention · doi:10.15430/jcp.2023.28.4.131 · Cited by 9
Jin, A., Cheng, H., Xia, L., Ye, S., & Yang, C. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120969958 · Cited by 9
Thorwald, M. A., Godoy-Lugo, J. A., Rodríguez, R., Stanhope, K. L., Graham, J. L., Havel, P. J., Forman, H. J., & Ortiz, R. M. (2022) · Antioxidants · doi:10.3390/antiox11050927 · Cited by 9
Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia
Pagano, M. A., Frezzato, F., Visentin, A., Trentin, L., & Brunati, A. M. (2022) · Cancers · doi:10.3390/cancers14194881 · Cited by 9
Fragoulis, A., Tohidnezhad, M., Kubo, Y., Wruck, C. J., Craveiro, R. B., Bock, A., Wolf, M. F., Pufe, T., Jahr, H., & Suhr, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097722 · Cited by 10
Mobasher, M. A., & Valverde, Á. M. (2014) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2014.893365 · Cited by 9
Huang, K., Ma, K., Hung, Y., Lo, L., Lin, K., Liu, P., Hu, M., & Chueh, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26861 · Cited by 9
Nrf2 Activation Ameliorates Hepatotoxicity Induced by a Heme Synthesis Inhibitor
Taguchi, K., Masui, S., Itoh, T., Miyajima, A., & Yamamoto, M. P. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy233 · Cited by 9
Revisiting Neuroblastoma: Nrf2, NF-κB and Phox2B as a Promising Network in Neuroblastoma
Peggion, S., Najem, S., Kolman, J. P., Reinshagen, K., & Raluy, L. P. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040200 · Cited by 8
Nrf2 in human cancers: biological significance and therapeutic potential
Tian, Y. (2024) · American Journal of Cancer Research · doi:10.62347/lzvo6743 · Cited by 9
The role of Nrf2 in immune cells and inflammatory autoimmune diseases: a comprehensive review
Xu, W., Yang, C., & Huang, A. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2401518 · Cited by 8
A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapy
García‐Yagüe, Á. J., Cañizares-Moscato, L., Encinar, J. A., Cazalla, E., Fernández-Ginés, R., Escoll, M., Rojo, A. I., & Cuadrado, A. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01157-3 · Cited by 8
Self-citationNRF2 activation in cancer and overview of NRF2 small molecule inhibitors
Ngo, H. H., Yu, B.-Y., Lee, J., Kim, H. W., & Keum, Y. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01557-x · Cited by 9
NRF2 as a guardian of health: from an ancient survival pathway to a modern therapeutic target
Tenreiro, S., Falcão, A. S., Bender, N., Bernátová, I., Berry, A., Cuadrado, A., Eppenberger, P., Giona, L., Grochot‐Przeczek, A., Heiß, E. H., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104217 · Cited by 8
Self-citationHuo, K., Ma, K.-G., Guo, Q.-Y., Duan, P., & Xu, J. B. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108718 · Cited by 8
Wang, X., Bian, Y., Wong, C. T. T., Lu, J., & Lee, S. M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1544244 · Cited by 8
Zhang, X., Lu, Y. F., He, N., & Wang, F. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112344 · Cited by 8
Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer
Son, S. W., Song, M. G., Yun, B. D., & Park, J. K. (2021) · Biomedicines · doi:10.3390/biomedicines9030263 · Cited by 8
The HO-1/CO System and Mitochondrial Quality Control in Skeletal Muscle
Gasier, H. G., Suliman, H. B., & Piantadosi, C. A. (2021) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000277 · Cited by 8
Protein levels in Keap1-Nrf2 system in human failing heart
Konishi, M., Baumgarten, A., Ishida, J., Saitoh, M., Anker, S. D., & Springer, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.128 · Cited by 8
Ye, M., Guo, X., Wang, H., Wang, Y., Qian, X., Deng, H., Wang, W., Yang, S., Ni, Q., Chen, J., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.018 · Cited by 8
Nrf2-Mediated Signaling as a Therapeutic Target in Alzheimer’s Disease
Bitra, V. R., Moshapa, F. T., Adiukwu, P. C., & Rapaka, D. (2024) · The Open Neurology Journal · doi:10.2174/011874205x319474240611070113 · Cited by 7
Cheng, I.-C., Chen, Y., Ku, C., Huang, Y.-W., & Yang, C. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00300 · Cited by 9
Xi, C., Palani, C. D., Takezaki, M., Shi, H., Horuzsko, A., Pace, B. S., & Zhu, X. (2024) · Antioxidants · doi:10.3390/antiox13030337 · Cited by 7
Vigor King mitigates spermatogenic disorders caused by environmental estrogen zearalenone exposure
Zuo, N., Wang, R. T., Bian, W.-M., Liu, X., Han, B. Q., Wang, J., Shen, W., & Li, L. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116757 · Cited by 7
Niture, S. K., Gnatt, A. L., & Jaiswal, A. K. (2013) · Journal of Cell Science · doi:10.1242/jcs.133819 · Cited by 7
RetractedTrostnikov, M. V., Veselkina, E. R., Krementsova, A. V., Boldyrev, S. V., Roshina, N. V., & PASYUKOVA, E. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00668 · Cited by 7
Degradation of human Lipin-1 by BTRC E3 ubiquitin ligase
Ishimoto, K., Hayase, A., Kumagai, F., Kawai, M., Okuno, H., Hino, N., Okada, Y., Kawamura, T., Tanaka, T., Hamakubo, T., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.159 · Cited by 7
Najumuddin, Fakhar, M., Gul, M., & Rashid, S. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.05.020 · Cited by 7
Lee, J., Zhong, X., Lee, J.-Y., Surh, Y., & Na, H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108162 · Cited by 7
WIP Modulates Oxidative Stress through NRF2/KEAP1 in Glioblastoma Cells
Escoll, M., Lastra, D., Robledinos-Antón, N., Wandosell, F. G., Antón, I. M., & Cuadrado, A. (2020) · Antioxidants · doi:10.3390/antiox9090773 · Cited by 7
Self-citationThe role of Nrf2 in autoimmunity and infectious disease: Therapeutic possibilities
Freeborn, R. A., & Rockwell, C. E. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2020.10.003 · Cited by 7
Redox Signaling and the Onset of the Inflammatory Cascade
Vázquez‐Medina, J. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805417-8.00003-2 · Cited by 8
Rathod, S., & Agrawal, Y. O. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04281-x · Cited by 6
Maeda, Y. K., Motooka, Y., Akatsuka, S., Tanaka, H., Mashimo, T., & Toyokuni, S. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103739 · Cited by 6
Advancements and perspectives of RBX2 as a molecular hallmark in cancer
Tao, Y., Dai, L., Liang, W., Li, X., Lyu, Y., Li, J., Li, Z., Shi, Z., Liang, X., Zhou, S., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147864 · Cited by 6
Sogabe, K., Nakamura, S., Higa, Y., Miki, H., Oda, A., Maruhashi, T., Sumitani, R., Oura, M., Takahashi, M., Nakamura, M., et al. (2024) · International Journal of Hematology · doi:10.1007/s12185-023-03705-9 · Cited by 6
Effects of Akt Activator SC79 on Human M0 Macrophage Phagocytosis and Cytokine Production
Lee, R. J., Adappa, N. D., & Palmer, J. N. (2024) · Cells · doi:10.3390/cells13110902 · Cited by 7
The Role of FBXW Subfamily of F-box Proteins in Tumorigenesis
Lau, A. W., Liu, Y., Tron, A. E., Inuzuka, H., & Wei, W. (2014) · Springer eBooks · doi:10.1007/978-3-319-05026-3_2 · Cited by 6
Fang, Y., Lian, Q., Zhang, X., Sun, F., Jia, S., & Zhao, W. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116829 · Cited by 5
Ozleyen, A., Kulabas, S. S., Novak, M. J., Cichoń, M., Heras, C. M. D. L., Honda, T., Doveston, R. G., Dinkova‐Kostova, A. T., Grochot‐Przeczek, A., & Tumer, T. B. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110847 · Cited by 5
Ren, X., Yu, J., Guo, L., & Zhang, Z. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01043-z · Cited by 5
Conan, P., Léon, A., Caroff, N., Rollet, C., Chaïr, L., Martin, J., Bihel, F. J. ‐., Mignen, O., Voisset, C., & Friocourt, G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1110163 · Cited by 5
The KEAP1-NRF2 system and neurodegenerative diseases
Uruno, A., & Yamamoto, M. P. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0005 · Cited by 8
Aripiprazole increases NAD(P)H–quinone oxidoreductase-1 and heme oxygenase-1 in PC12 cells
Kaneko, Y. S., Takayanagi, T., Nagasaki, H., Kodani, Y., Nakashima, A., Mori, K., Suzuki, A., Itoh, M., Kondo, K., Nagatsu, T., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1350-8 · Cited by 5
Dual targeting of Keap1 and Gsk-3 by hexaraphane in the regulation of transcription factor Nrf2
García‐Yagüe, Á. J., Cueto-Diaz, E. J., Escoll, M., Okunishi, I., Hayes, J. D., Rodrı́guez-Franco, M. I., Rojo, A. I., & Cuadrado, A. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.051 · Cited by 4
Self-citationEskandari, N., Delisi, D., Saatloo, M. V., Keceli, G., Pinheiro, N., Eblen, S. T., Paolocci, N., & Gentile, S. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103942 · Cited by 4
Oshikiri, H., Taguchi, K., Hirose, W., Taniyama, Y., Kamei, T., Siegel, D. M., Ross, D., Kitson, R. R. A., Baird, L., & Yamamoto, M. P. (2024) · Molecular and Cellular Biology · doi:10.1080/10985549.2024.2438817 · Cited by 4
Nrf2 Regulates the Expression of CYP2D6 by Inhibiting the Activity of Krüppel-Like Factor 9 (KLF9)
Siswanto, F. M., Handayani, M. D. N., Firmasyah, R. D., Oguro, A., & Imaoka, S. (2023) · Current Drug Metabolism · doi:10.2174/0113892002271342231013095255 · Cited by 4
Transcription Factor NRF2 in Endothelial Functions
Kondratenko, N. D., Zinovkina, L. A., & Zinovkin, R. A. (2023) · Molecular Biology · doi:10.1134/s0026893323060092 · Cited by 4
Deng, J., Li, N., Hao, L., Li, S., Nie, A., Zhang, J., & Hu, X. (2024) · PeerJ · doi:10.7717/peerj.17692 · Cited by 4
Li, Y., Cheng, G., & Yang, G. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.029 · Cited by 4
Sulfhydryl-Reactive Phytochemicals as Dual Activators of Transcription Factors NRF2 and HSF1
Dinkova‐Kostova, A. T., Zhang, Y., Naidu, S. D., Kostov, R. V., Pheely, A., & Calabrese, V. (2013) · Springer eBooks · doi:10.1007/978-3-319-00581-2_6 · Cited by 4
Aldaba-Muruato, L. R., Muñoz‐Ortega, M. H., Campos-Esparza, M. D. R., Macías-Pérez, J. R., MÁRQUEZ-MUÑOZ, N. A., VILLALOBOS-SANTOS, A. G., & Ventura‐Juárez, J. (2016) · Parasitology · doi:10.1017/s0031182016001967 · Cited by 4
Lu, M., Yang, Z., Xin, Y., Zhang, Y., Jiang, S., Zhu, J., You, Q., Zhao, Z., & Jiang, Z. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.05.030 · Cited by 3
Nuclear factor erythroid 2-related factor 2 in Alzheimer's disease
Murphy, K. E., & Park, J. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00015-3 · Cited by 3
Dittmar, M. C., Tohidnezhad, M., Fragoulis, A., Bücker, A., Stein, M., Pufe, T., & Kubo, Y. (2024) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2024.152260 · Cited by 3
Li, C., Zhang, Q., Zhang, B., Liang, H. Y., Ma, L. N., & Salman, M. (2025) · BMC Veterinary Research · doi:10.1186/s12917-024-04467-0 · Cited by 3
Lu, L.-J., Hu, N., Chen, H., Wang, S., Deng, Y. J., Lin, Z., Wang, Z., Zhu, X., Liu, X., Liu, L., et al. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100068 · Cited by 3
NRF2-mediated persistent adaptation of oesophageal adenocarcinoma cells to HER2 inhibition
Zhang, W., Lang, J., Chattrakarn, S., Wong, C. W., Li, S.-Y., Kan, K., Liu, H., Gu, W., Zhang, J., Westermarck, J. K., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03459-0 · Cited by 3
The Role of Nonneuronal Nrf2 Pathway in Ischemic Stroke: Damage Control and Potential Tissue Repair
Yang, T., Sun, Y., & Zhang, F. (2016) · Springer series in translational stroke research · doi:10.1007/978-3-319-32337-4_18 · Cited by 3
Zhou, L., Hu, C., Li, Y., & Wang, B. (2022) · Bioengineered · doi:10.1080/21655979.2022.2030592 · Cited by 3
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia
Villa‐Morales, M., Pérez-Gómez, L., Pérez-Gómez, E., López‐Nieva, P., Fernández‐Navarro, P., & Santos, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210350 · Cited by 4
Key Transcription Factors Linking Macular Degeneration and Alzheimer’s Disease
Eichenbaum, J. W. (2019) · World Journal of Ophthalmology & Vision Research · doi:10.33552/wjovr.2019.01.000516 · Cited by 3
Neurochemical Aspects of Oxidative and Nitrosative Stress
Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_6 · Cited by 3
Thiriet, M. (2018) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-3-319-89315-0_6 · Cited by 3
Das, T., Brahmachari, P., & Ukil, A. (2025) · mBio · doi:10.1128/mbio.02581-25 · Cited by 2
Cazalla, E., García‐Yagüe, Á. J., Pajares, M., Jiménez-Villegas, J., Escoll, M., Rojo, A. I., & Cuadrado, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020770 · Cited by 2
Self-citationWu, Y., Zhang, Y., Zhang, S., Yang, H., & Ci, X. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124214 · Cited by 2
Huu, T. N., Thanh, H. D., Kim, M., Sah, D. K., Trinh, V. H., Yoon, H.-J., Choi, J. M., Lee, G.-H., Kim, S., & Lee, S.-R. (2026) · Communications Biology · doi:10.1038/s42003-026-09797-3 · Cited by 2
NRF2 as a Therapeutic Target in Dermatological Disorders: Mechanisms and Molecules
Khiar-Fernández, I., Khiar‐Fernández, N., Pereyra-Rodríguez, J.-J., & Fernández, I. (2026) · Pharmaceuticals · doi:10.3390/ph19030497 · Cited by 6
AMPK as a regulatory node in cell death
Rong, D., You, S., & Shen, H. (2026) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2026.02.006 · Cited by 3
Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues
O’Donovan, D. H., Winter-Holt, J. J., Collie, G. W., Cuomo, M. E., McGarry, D., Fox, M., Seong, B. K. A., Grazini, U., Barton, P., Longmire, D., et al. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.5c01006 · Cited by 2
Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibition
Gebru, M. T., & Stokoe, D. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1856014 · Cited by 2
Jebanesan, D. Z. P., Illangeswaran, R. S. S., Rajamani, B. M., Vidhyadharan, R. T., Das, S., Bijukumar, N. K., Balakrishnan, B., Mathews, V., Velayudhan, S. R., & Balasubramanian, P. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05742-8 · Cited by 2
The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
Zhang, D., Li, J., Zhang, C., Xue, J., Li, P., Shang, K., Zhang, X., & Lang, B. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0935 · Cited by 2
Chen, Y., Zhu, L., Ye, Y., Song, M., Wang, W., Shen, B. Q., Guo, B., Yan, X., & Qi, P. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2025.107513 · Cited by 2
Targeting the Keap1/Nrf2 axis in cancer: molecular mechanisms and pharmacological interventions
Xia, Y., Xu, Z., Yuan, X., & Chu, Q. (2025) · Investigational New Drugs · doi:10.1007/s10637-025-01578-9 · Cited by 2
NRF2 and Age-Dependent RPE Degeneration
Chen, Y., Zhao, Z., Sternberg, P. W., & Cai, J. (2012) · InTech eBooks · doi:10.5772/28167 · Cited by 2
Kalkman, H. O. (2021) · Psychiatry International · doi:10.3390/psychiatryint2010008 · Cited by 2
Sensing Oxidative Stress: The NRF2 Signaling Pathway
de la Vega, M. R., Dodson, M. B., & Zhang, D. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95613-7 · Cited by 1
Scope of Theoretical Approaches Studying the Ligand-Nrf2 Interactions
Soriano-Ursua, M. A., Ocampo-Néstor, A. L., Rosalez, M. N., Farfán‐García, E. D., Madrigal‐Santillán, E., Morales‐González, Á., & Morales‐González, J. A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007160 · Cited by 1
Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis
Davidovich, P. B., Nikolaev, D., Khadiullina, R., Gurzhiy, V. V., & Bulatov, E. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.130058 · Cited by 1
Shao, C., Feng, X., Hao, R., Chen, Y., Zhang, T., Yan, S., Chen, Y., Wang, X., & Luo, H. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70149 · Cited by 1
Yuan, C., Dong, P., Wang, J., Mao, P., Wang, Z., Dong, J., Guo, L., Liu, K., Cui, L., Li, J., et al. (2025) · Veterinary Research · doi:10.1186/s13567-025-01675-w · Cited by 2
Protective effects of Ganoderma lucidum polysaccharide peptides against cisplatin-induced toxicity
Hou, Z., Ji, W., Yang, S., Zhang, Y., Yang, T., Wang, L.-F., Luo, H., Lin, D., Yang, B., Chen, X., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121210 · Cited by 1
Multi-pathway and gut microbiota mechanisms underlying the antioxidant effects of formononetin
薛梅, Kong, L., Chen, Y., Hou, L., & Hou, J. (2026) · South African Journal of Botany · doi:10.1016/j.sajb.2026.04.023 · Cited by 1
Nitric oxide redox signaling as a convergent mechanism in aging and fibrosis
Guo, X., Cao, Y., Liu, L., Peng, Y., Du, Y., Yang, F., & Huang, D. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103156 · Cited by 1
Multiple Modes of Nrf2 Regulation and Transcriptional Response
Mathew, S. T., & Hammarsten, O. (2016) · InTech eBooks · doi:10.5772/65295 · Cited by 1
Zyla, K., & Plafker, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821562-3.00042-3 · Cited by 1
Wang, X.-C., Wang, Z., Wang, C.-L., Xue, H.-L., Wu, M., Chen, L., Fan, C., Xu, J.-H., & Xu, L. (2023) · Biological Rhythm Research · doi:10.1080/09291016.2023.2252221 · Cited by 1
ncRNAs Orchestrate Chemosensitivity Induction by Neddylation Blockades
Pérez-González, A., Ramírez‐Díaz, I., Guzmán-Linares, J., Sarvari, P., Sarvari, P., & Rubio, K. (2024) · Cancers · doi:10.3390/cancers16040825 · Cited by 1
A new mouse strain with mutation in the NFE2L2 (NRF2 gene
Egorov, E. S., Kondratenko, N. D., Averina, O. A., Permyakov, O. A., Emelyanova, M., Prikhodko, A. S., Zinovkina, L. A., Владимирович, С. П., & Zinovkin, R. A. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523120035 · Cited by 1
USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCC
Zhang, S., Ding, F., Jia, F., & Lu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-01913-9 · Cited by 1
Regulation of Antioxidant Nrf2 Signaling: An Important Pathway in COPD
Chatterjee, N., & Chatterjee, D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_7 · Cited by 1
Reactive oxygen species, redox signaling, and regulation of vascular endothelial signaling
Allen, K. N., & Vázquez‐Medina, J. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816196-8.00011-4 · Cited by 1
Wang, H., Liu, S., Guo, J., Deng, T., Fu, J., Xu, Y., Qu, W., Zhang, Q., & Pi, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85215-9.00035-0 · Cited by 1
Regulation of NRF2 signaling pathway and the hallmarks of aging: An overview
Medoro, A., Scapagnini, G., & Davinelli, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19247-0.00004-7 · Cited by 1
Targeting Nrf2 in inflammation and cancer
Cowan, J. (2014) · UEA Digital Repository (University of East Anglia) · Cited by 1
Metadata
- Authors
- Rada, P., Rojo, A. I., Chowdhry, S., McMahon, M., Hayes, J. D., & Cuadrado, A.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- University of Dundee (GB)
- Corresponding author
- Cuadrado, Antonio
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-03-01
- Volume
- 31
- Issue
- 6
- Pages
- 1121-1133
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3067901
- OpenAlex
- W2118394016
- Cited by
- 759
- References
- 55
- Citations by year
- 2026: 40 · 2025: 36 · 2024: 53 · 2023: 76 · 2022: 60 · 2021: 71 · 2020: 80 · 2019: 50 · 2018: 47 · 2017: 59 · 2016: 49 · 2015: 51 · 2014: 27 · 2013: 27 · 2012: 21
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Nrf2, glycogen synthase kinase-3, β-TrCP, protein degradation, serine phosphorylation, ubiquitination, transcription factor regulation, redox signaling
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Kelch-Like ECH-Associated Protein 1, Amino Acid Sequence, Animals, Cell Line, Cytoskeletal Proteins, Humans, Molecular Sequence Data, Mutation, Phosphorylation, Serine, Protein Structure, Tertiary, Glycogen Synthase Kinase 3, Ubiquitin-Protein Ligases, beta-Transducin Repeat-Containing Proteins, Adaptor Proteins, Signal Transducing, NF-E2-Related Factor 2, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review